Healthcare
We create and invest in leading companies in therapeutics, medtech, and health IT & services.

32
Thirty two products and drugs approved
With another 12 drugs in phase 3. Typically, only 1 in 5,000 drugs makes it from idea to market.
29
Twenty nine companies created from scratch
If we can't find a company solving an important problem, we create one ourselves - just like we did with Innovent, Denali, Beam and Prime Medicine to name a few.
$2.5B
Over two and a half billion dollars over nine funds
Without the pressure of fundraising from outside investors, we're privileged to champion companies that help heal the world.